findmyKOL

Sabina Wallach, MD

Basic profile

Boston Medical Center

ORCIDNone on fileNPI
RegionLa Jolla, CA · WestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1989Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sabina Wallach is an Oncology physician affiliated with Boston Medical Center. OpenAlex indexes 10 publications with 240 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

240citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
73companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

9850 Genesee Ave
#400
La Jolla, CA 920371212

Telephone

858-558-8666

Registry record last updated 16 Aug 2007.

View the NPPES registry record

Industry payments

73 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    53.6%
    Iron, parenteral preparations53.3%
    Ferric carboxymaltose100%
    Part B, office-administered12 patients
    Factor Xa inhibitor0.1%
    Eliquis100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    43.9%
    RANK Ligand Inhibitor43.1%
    Denosumab100%
    Part B, office-administered117 patients
    Bisphosphonate0.8%
    Zoledronic acid100%
    Part B, office-administered38 patients
  • Cancer & immunology

    0.7%
    Aromatase Inhibitor0.4%
    Anastrozole61%Letrozole27%Exemestane12%
    Part D<11 patients
    Antimetabolite0.1%
    Hydroxyurea100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”